Screener
BridgeBio Pharma BBIO Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from BridgeBio Pharma’s reported figures.
Based on trailing twelve months.
The source filing: BridgeBio Pharma’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:31 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001743881-26-000019
FAQ
- What is BridgeBio Pharma's net margin?
- BridgeBio Pharma (BBIO) reported net margin of -125.9% in Q1 2026.
- How has BridgeBio Pharma's net margin changed year-over-year?
- BridgeBio Pharma's net margin increased by 76.3% year-over-year, from -531.2% to -125.9%.
- What is the long-term trend for BridgeBio Pharma's net margin?
- Over 4 years (2021 to 2025), BridgeBio Pharma's net margin has grown at a -35.5% compound annual growth rate (CAGR), from -841.2% to -146%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about BridgeBio Pharma's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude